logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
R

Roy Fleischmann

Metroplex Clinical Research Center

80H指数
490论文数
3.2W被引数
收录论文 149
发表时间
logo
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials)奥洛基珠单抗改善活动性类风湿关节炎患者报告结局，最长可达106周（来自III期随机临床试验开放标签扩展研究的结果）
errRheumatology and Therapy
IF2.9
err2026-05-16
err0
errOAAI
errRoy M. Fleischmann; Vibeke Strand; Eugen Feist; Tatiana Lisitsyna; Jeffrey A. Sparks; Evgeny Nasonov; Mikhail Samsonov; Sergey Grishin; Alina Egorova; Sofiya Kuzkina; Josef S. Smolen
err分享
err收藏
Baseline interleukin-10 levels as a predictive biomarker for achieving clinical response with abatacept in disease-modifying antirheumatic drug-naive and anticitrullinated protein antibody-positive patients with early rheumatoid arthritis基线白细胞介素-10水平作为预测阿达木单抗治疗早期类风湿关节炎患者临床反应的生物标志物（适用于疾病 modifying antirheumatic drug-naive 且抗瓜氨酸化蛋白抗体阳性的患者）
errArthritis & Rheumatology
IF10.9
err2026-02-24
err0
PREAI
errJinqi Liu PhD; Yicong Li PhD; Kai Fu PhD; Chun Wu PhD; Peter Schafer PhD; Sean E. Connolly PhD; Ian M. Catlett PhD; Michael A. Maldonado MD; Robert Wong MD; Paul Emery FMedSci; Yoshiya Tanaka MD; Vivian P. Bykerk MD; Clifton O. Bingham MD; Thomas W. J. Huizinga MD, PhD; Roy Fleischmann MD
err分享
err收藏
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis按体重指数校正的甲氨蝶呤剂量下，托法替尼与阿达木单抗治疗类风湿关节炎的有效性和安全性：一项事后分析
errRheumatology and Therapy
IF2.9
err2026-01-22
err0
errOAAI
errTsutomu Takeuchi; Yoshiya Tanaka; Hisashi Yamanaka; Kunihiro Yamaoka; Naonobu Sugiyama; Noriko Iikuni; Shigeyuki Toyoizumi; Kenneth Kwok; Wen-Chan Tsai; Eduardo Mysler; Robert J. Moots; Josef S. Smolen; Roy Fleischmann
err分享
err收藏
Have we found a true disease-modifying osteoarthritis drug (DMOAD) or is there still much work to be done?我们是否找到了真正的疾病修饰性骨关节炎药物（DMOAD）？还是说仍然有大量工作需要完成？
errRHEUMATOLOGY
IF4.4
err2025-02-21
err0
PREAI
errFleischmann, R
err分享
err收藏
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis PatientsTofacitinib与肿瘤坏死因子抑制剂在心血管风险富集的类风湿关节炎患者中的静脉血栓栓塞风险
errARTHRITIS & RHEUMATOLOGY
IF10.9
err2024-04-19
err2
errOAAI
errCharles-Schoeman, Christina; Fleischmann, Roy; Mysler, Eduardo; Greenwald, Maria; Ytterberg, Steven R.; Koch, Gary G.; Bhatt, Deepak L.; Wang, Cunshan; Mikuls, Ted R.; Chen, All-shine; Connell, Carol A.; Woolcott, John C.; Menon, Sujatha; Chen, Yan; Lee, Kristen; Szekanecz, Zoltan
err分享
err收藏
TYK2: an emerging therapeutic target in rheumatic diseaseTYK2：风湿性疾病中新兴的治疗靶点
errNATURE REVIEWS RHEUMATOLOGY
IF32.7
err2024-03-11
err3
PREAI
errMorand, Eric; Merola, Joseph F.; Tanaka, Yoshiya; Gladman, Dafna; Fleischmann, Roy
err分享
err收藏
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician (Vol 20, Pg 101, 2024)JAK抑制剂在类风湿关节炎中的疗效和安全性: 针对执业临床医生的更新 (第20卷，101页，2024)
errNATURE REVIEWS RHEUMATOLOGY
IF32.7
err2024-02-01
err0
errOAAI
errSzekanecz, Zoltan; Buch, Maya H.; Charles-Schoeman, Christina; Galloway, James; Karpouzas, George A.; Kristensen, Lars Erik; Ytterberg, Steven R.; Hamar, Attila; Fleischmann, Roy
err分享
err收藏
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinicianJAK抑制剂在类风湿关节炎中的疗效和安全性: 针对执业临床医生的更新
errNATURE REVIEWS RHEUMATOLOGY
IF32.7
err2024-01-12
err27
PREAI
errSzekanecz, Zoltan; Buch, Maya H.; Charles-Schoeman, Christina; Galloway, James; Karpouzas, George A.; Kristensen, Lars Erik; Ytterberg, Steven R.; Hamar, Attila; Fleischmann, Roy
err分享
err收藏
Is There a Role for Vagal Nerve Stimulation in the Treatment of Rheumatoid Arthritis?迷走神经刺激在类风湿关节炎的治疗中是否有作用？
errARTHRITIS & RHEUMATOLOGY
IF10.9
err2023-09-21
err0
PREAI
errFleischmann, Roy
err分享
err收藏
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study
errLANCET RHEUMATOLOGY
IF16.4
err2023-09-01
err6
PREAI
errFleischmann, Roy M.; Saikali, Wassim; Lakhanpal, Sharad; Alvarez, Daniel F.; Cox, Donna S.; Ianos, Claudia Ana; Zhang, Wuyan; Cronenberger, Carol; Wang, Karen
err分享
err收藏
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2022-08-25
err33
errOAAI
errSmolen, Josef S.; Feist, Eugen; Fatenejad, Saeed; Grishin, Sergey A.; Korneva, Elena, V; Nasonov, Evgeniy L.; Samsonov, Mikhail Y.; Fleischmann, Roy M.
err分享
err收藏
Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis持续活动性类风湿关节炎患者的多生物标志物疾病活动与临床疾病活动评分之间的差异
errARTHRITIS CARE & RESEARCH
IF3.3
err2022-05-24
err1
PREAI
errFleischmann, Roy; Liu, Jingyu; Zhu, Julie; Segurado, Oscar G.; Furst, Daniel E.
err分享
err收藏
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?JAK抑制剂的十年: 我们学到了什么，未来可能是什么？
errARTHRITIS & RHEUMATOLOGY
IF10.9
err2021-11-02
err43
errOAAI
errLiu, Christine; Kieltyka, Jacqueline; Fleischmann, Roy; Gadina, Massimo; O'Shea, John J.
err分享
err收藏
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND类风湿关节炎患者接受巴瑞替尼治疗5年期间关节结构损伤的放射学进展：RA-BEYOND研究结果
errJOURNAL OF RHEUMATOLOGY
IF3.4
err2021-09-15
err7
errOAAI
errvan der Heijde, Desiree; Kartman, Cynthia E.; Xie, Li; Beattie, Scott; Schlichting, Douglas; Mo, Daojun; Durez, Patrick; Tanaka, Yoshiya; Fleischmann, Roy
err分享
err收藏
Current Treatment Strategies in Rheumatoid Arthritis After Methotrexate Are Not Enough to Maintain Sustained Remission: There Is No Holy Grail!甲氨蝶呤后类风湿关节炎的当前治疗策略不足以维持持续缓解: 没有圣杯!
errARTHRITIS & RHEUMATOLOGY
IF10.9
err2021-05-28
err0
errOAAI
errPope, Janet E.; Nash, Peter; Fleischmann, Roy
err分享
err收藏
The Results of Well-conducted Negative Clinical Trials Should Be Reported in a Peer-reviewed Journal进行良好的阴性临床试验的结果应在同行评审的期刊上报告
errJOURNAL OF RHEUMATOLOGY
IF3.4
err2021-04-15
err0
errOAAI
errFleischmann, Roy
err分享
err收藏
Tofacitinib monotherapy in psoriatic arthritis-what is missing?
errLANCET RHEUMATOLOGY
IF16.4
err2021-01-01
err0
PREAI
errFleischmann, Roy
err分享
err收藏
Efficacy and Safety of Long-Term Baricitinib With and Without Methotrexate for the Treatment of Rheumatoid Arthritis: Experience With Baricitinib Monotherapy Continuation or After Switching From Methotrexate Monotherapy or Baricitinib Plus Methotrexate长期使用或不使用甲氨蝶呤的Baricitinib治疗类风湿关节炎的疗效和安全性: Baricitinib单药治疗或从甲氨蝶呤单药治疗或Baricitinib加甲氨蝶呤转换后的经验
errARTHRITIS CARE & RESEARCH
IF3.3
err2020-07-29
err25
PREAI
errFleischmann, Roy; Takeuchi, Tsutomu; Schiff, Michael; Schlichting, Douglas; Xie, Li; Issa, Maher; Stoykov, Ivaylo; Lisse, Jeffrey; Martinez-Osuna, Pindaro; Rooney, Terence; Zerbini, Cristiano A. F.
err分享
err收藏
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis背景糖皮质激素治疗对类风湿关节炎患者阿巴西普或阿达木单抗的疗效和安全性没有影响
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2020-06-26
err1
errOAAI
errDegboe, Yannick; Schiff, Michael; Weinblatt, Michael; Fleischmann, Roy; Ahmad, Harris A.; Constantin, Arnaud
err分享
err收藏
Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis
errEXPERT OPINION ON DRUG SAFETY
IF3.1
err2020-06-16
err8
PREAI
errFleischmann, Roy; Furst, Daniel E.
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
D
Deepak L. Bhatt
H 指数: 197 · 论文数: 3.7K
P
Paul Emery
H 指数: 158 · 论文数: 1.6K
D
Désirée van der Heijde
H 指数: 158 · 论文数: 1.3K
I
Iain B. McInnes
H 指数: 144 · 论文数: 1.3K
D
Dafna D. Gladman
H 指数: 143 · 论文数: 1.6K
查看更多